These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18683812)

  • 21. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Insight: lycopene in the prevention and treatment of prostate cancer.
    Guns ES; Cowell SP
    Nat Clin Pract Urol; 2005 Jan; 2(1):38-43. PubMed ID: 16474575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of prostate cancer.
    DePrimo SE; Shinghal R; Vidanes G; Brooks JD
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):445-57. PubMed ID: 11525290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: chemoprevention update 2005.
    Fleshner N; Al Azab R
    Can J Urol; 2005 Jun; 12 Suppl 2():2-4. PubMed ID: 16018824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells.
    Scaglione F; Lucini V; Pannacci M; Caronno A; Leone C
    Pharmacology; 2008; 82(4):270-5. PubMed ID: 18849646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes.
    Goyal A; Delves GH; Chopra M; Lwaleed BA; Cooper AJ
    BJU Int; 2006 Oct; 98(4):907-11. PubMed ID: 16978292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer.
    Fleshner NE; Kucuk O
    Urology; 2001 Apr; 57(4 Suppl 1):90-4. PubMed ID: 11295603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease.
    Feifer AH; Fleshner NE; Klotz L
    J Urol; 2002 Jul; 168(1):150-4; discussion 154. PubMed ID: 12050511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of lipidic extracts of saladette tomato pomace and Serenoa repens on prostate and bladder health in obese male Wistar rats.
    Espinosa-Juárez JV; Colado-Velázquez JI; Mailloux-Salinas P; Medina-Contreras J; Correa-López PV; Gómez-Viquez NL; Meza-Cuenca F; Huang F; Bravo G
    J Sci Food Agric; 2017 Oct; 97(13):4451-4458. PubMed ID: 28276068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer properties of carotenoids in prostate cancer. A review.
    Soares Nda C; Teodoro AJ; Lotsch PF; Granjeiro JM; Borojevic R
    Histol Histopathol; 2015 Oct; 30(10):1143-54. PubMed ID: 26058846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary and alternative medicine patients are talking about: lycopene.
    Lee CO
    Clin J Oncol Nurs; 2005 Apr; 9(2):245-6. PubMed ID: 15853167
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
    Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
    Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lycopene and prostate cancer.
    Barber NJ; Barber J
    Prostate Cancer Prostatic Dis; 2002; 5(1):6-12. PubMed ID: 15195123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of PC-SPES, selenium, and vitamin E in prostate cancer.
    Das P; Kaplan I
    Oncology (Williston Park); 2002 Mar; 16(3):285-91; discussion 291, 295-6, 299-300. PubMed ID: 15046388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature.
    Giovannucci E
    J Nutr; 2005 Aug; 135(8):2030S-1S. PubMed ID: 16046732
    [No Abstract]   [Full Text] [Related]  

  • 40. Lycopene for prevention and treatment of prostate cancer.
    Everson KM; McQueen CE
    Am J Health Syst Pharm; 2004 Aug; 61(15):1562-6. PubMed ID: 15372829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.